Jump to content

Teva granted exclusive rights to generic risperdal

Recommended Posts

Umm I just posted on this a week and a half ago. My source has different info:

Bloomburg News:


The US patent on Risperdal expires June 29th, 2008. Several companies including Teva Pharmaceuticals and Maylan have been fighting over first approval. The FDA was going to grant permission simultaneously to all generic companies. Unfortunately, a US court has ordered that Teva will have 6 months of exclusive marketing, meaning we will have to wait till next winter for true price competition.


Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...